Topical Wound Spray HP802-247 clinical trials
Also written HP802-247.
How each study uses Topical Wound Spray HP802-247 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HP802-247
- 8
Studies by the year they started
8 studies that test it; most in 2012 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Topical Wound Spray HP802-247 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2CompletedPhase 3HealthpointNCT01737762Written as HP802-247How we know
- Study of Survival Duration for Donor Skin Cells in Skin Biopsy WoundsCompletedPhase 1HealthpointNCT01190865Written as HP802-247How we know
- Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery PatientsCompletedPhase 2HealthpointNCT01359735Written as HP802-247How we know
- Dose Finding Study of HP802-247 in Venous Leg UlcersCompletedPhase 2HealthpointNCT00852995Written as HP802-247How we know
- Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg UlcersTerminatedPhase 3HealthpointNCT01853384Written as HP802-247How we know
- A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg UlcersTerminatedPhase 2HealthpointNCT02154087Written as HP802-247How we know
- Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg UlcersCompletedPhase 3HealthpointNCT01656889Written as HP-802-247How we know
- A Pilot Study of HP802-247 in Dystrophic Epidermolysis BullosaWithdrawnPhase 2HealthpointNCT01528306Written as HP802-247How we know